Physician profile
John T Gallagher
NPI 1508846957
$3,647.06
in general payments reported to CMS, 2019-2025
28 companies · $746 in 2025
The $746 reported for 2025 was more than what 82% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $328 · 2021: $306 · 2022: $396 · 2023: $633 · 2024: $811 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,190.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $723.75 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $616.43 | 2021-2025 | Nucala |
| Optinose US, INC. | $472.06 | 2019-2025 | |
| Inspire Medical Systems, INC. | $336.90 | 2024-2025 | Inspire |
| Genzyme Corporation | $320.55 | 2023-2025 | |
| Stryker Corporation | $214.04 | 2019-2025 | Xpress Ent Dilation System, Latera, Nasopore |
| Alk-Abello, INC | $125.47 | 2019-2023 | Ragwitek, Odactra, Grastek |
| Acclarent, INC | $112.69 | 2019-2022 | |
| Aerin Medical INC. | $86.65 | 2019-2024 | |
| Intersect Ent, INC. | $68.21 | 2019-2021 | |
| Smith+Nephew, INC. | $67.07 | 2021-2025 | Halo, Tula |
| Arbor Pharmaceuticals, INC. | $60.77 | 2019-2020 | |
| Arrinex, INC. | $50.11 | 2019 | |
| Merck Sharp & Dohme LLC | $49.85 | 2023 | |
| Abiomed | $36.72 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $35.43 | 2020 | |
| Cochlear Americas | $30.44 | 2020 | |
| Olympus America INC. | $29.92 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $29.22 | 2023 | Ryaltris, Kloxxado |
| Urovant Sciences INC | $28.54 | 2022 | |
| Merz North America, INC. | $24.73 | 2019 | |
| Davol INC. | $24.48 | 2019 | |
| Paratek Pharmaceuticals, INC. | $22.15 | 2025 | Nuzyra, Xhance |
| Amgen INC. | $21.13 | 2025 | Tezspire |
| Fujifilm New Development USA, INC. | $20.68 | 2019 | |
| Phadia US INC. | $15.77 | 2021 | |
| Advanced Respiratory, INC | $12.27 | 2019 | |
| Cook Medical LLC | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.